Report #2870333

Received Nov 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: MI
Recovered: Unknown
Vaccinated: Oct 20, 2025
Onset: Oct 20, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	3	93N4J	—

Symptoms (1)

Extra dose administered

Symptom narrative

Shingrix plus third dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 59-year-old female patient who received Herpes zoster (Shingrix) (batch number 93N4J, expiry date 25-APR-2027) for prophylaxis. Previously administered products included Shingrix (received 1st dose on unknown date) and Shingrix (received 2nd dose on unknown date). On 20-OCT-2025, the patient received the 3rd dose of Shingrix. On 20-OCT-2025, an unknown time after receiving Shingrix, the patient experienced extra dose administered (Verbatim: Shingrix plus third dose). The outcome of the extra dose administered was not applicable. Additional Information: GSK receipt date: 20-OCT-2025 Reporter stated a third dose of Shingrix was given inadvertently to a patient, reporter stated patient did not had a reaction. The batch number was not provided and a request for this information has been made.